SCHEMBL7344839

SCHEMBL7344839

COC(=O)C(C(=O)OCc1ccccc1)N(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.51
▸ MAPT P10636 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ ABCB1 P08183 1/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ TRPM8 Q7Z2W7 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ CTSL P07711 2/20 0.44
▸ CTSB P07858 2/20 0.44
▸ CTSS P25774 2/20 0.44
▸ CTSK P43235 2/20 0.44
▸ KYNU Q16719 1/20 0.44
▸ LTA4H P09960 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27718490 0.85 ALDH1A1 (0.58) ALDH1A1MAPTHPGDABCB1L3MBTL1
SCHEMBL7345614 0.82 ALDH1A1 (0.46) ALDH1A1MAPTHPGDABCB1L3MBTL1
Trimethylammonium SCHEMBL28191476 0.80 ALDH1A1 (0.58) ALDH1A1MAPTHPGDABCB1L3MBTL1
SCHEMBL7213716 0.78 ALDH1A1 (0.56) ALDH1A1MAPTL3MBTL1KMT2AMAPK1
SCHEMBL26290931 0.78 ALDH1A1 (0.56) ALDH1A1MAPTHPGDL3MBTL1KMT2A
SCHEMBL4712055 0.78 ALDH1A1 (0.42) ALDH1A1MAPTHPGDABCB1L3MBTL1
SCHEMBL1549936 0.77 ALDH1A1 (0.64) ALDH1A1L3MBTL1KMT2AMAPK1SLC6A2
SCHEMBL14202766 0.77 NPC1 (0.51) ALDH1A1MAPTHPGDL3MBTL1KMT2A
SCHEMBL7213707 0.77 ALDH1A1 (0.55) ALDH1A1MAPTL3MBTL1KMT2AMAPK1
SCHEMBL7424592 0.77 ALDH1A1 (0.55) ALDH1A1L3MBTL1KMT2AMAPK1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 — — US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 — — EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 — — US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 — — EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 — — WO disclosed
Send feedback